|    Join     |    Donate    |   Store    |   About NAMS

Blog: MenoPause ~ take time to think about it

  • You got your wish! Nonhormonal alternatives have arrived

    by Margery Gass | Aug 12, 2013
    Earlier this year, we asked women whether they thought there was a need for prescription nonhormonal treatments for menopausal symptoms. Overwhelmingly (89%), women said “yes!” We took that message to the FDA. The good news is that now there are two new approved treatment options for menopausal symptoms. Ospemiphene (Osphena) received FDA approval in February for painful sex that can be a consequence of the changes in and around the vagina that can come with low estrogen levels. Then in June, the FDA approved low-dose paroxetine (Brisdelle) for moderate to severe hot flashes. Ospemiphene acts like an estrogen in some tissues, but not others. The major advantage is its estrogen-like activity in the vagina and surrounding tissues, which keeps them supple and moist. It acts on the uterus as well, so you and your healthcare provider need to be alert to any unusual vaginal bleeding. Paroxetine is a name you might have heard before because in higher doses, it’s sold as the antidepressant Paxil. It doesn’t take much to reduce hot flashes, so the dose is lower than that used for antidepressant activity. It carries the same warnings as the antidepressant formula, so be sure to discuss all treatment options with your healthcare provider to determine if it is right for you.

    This is a milestone year. For decades, hormone therapy has been the only medication approved for menopausal symptoms. Now there are choices. We hope this encourages others to conduct research in the field of menopause.
    4 Comments

MenoPause: the blog!

Posts to our Blog are written by NAMS staff members and Dr. Margery Gass. All posts are reviewed and edited by Dr. Gass. We strive to bring you the most recent and interesting information about various aspect of menopause and midlife health. We accept no advertising for our website. We want you to have accurate, unbiased, evidence-based information. 

Margery L.S. Gass, MD, NCMP
NAMS Executive Director

An internationally recognized leader in the field of menopause, Dr. Gass became Executive Director of The North American Menopause Society in 2010. Dr. Gass has been an investigator on numerous research projects, including serving as a principal investigator for the Women’s Health Initiative, and has published and presented on a wide range of topics related to menopause, including osteoporosis, sexual dysfunction, and hormone therapy.

Categories

Recent posts

Copyright© 2014 |  Home  |  Privacy Policy  |   Site Map |
This website is certified by Health On the Net Foundation. Click to verify.

This site complies
with the HONcode
standard
 
for
trustworthy health

information:
verify here.

5900 Landerbrook Drive, Suite 390 - Mayfield Heights, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 2 + 0.